Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 164Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Stronger Neo-Minophagen C And Glycyron

02 1Stronger Neo-Minophagen C and Glycyron Tablets

03 1Stronger Neo-Minophagen C and Glycyron

PharmaCompass

01

Brand Name : Stronger Neo-Minophagen C and Glycyron Tablets

Glycyrrhizin

arrow
ELCC
Not Confirmed

Brand Name : Stronger Neo-Minophagen C and Glycyron Tablets

arrow
ELCC
Not Confirmed

Glycyrrhizin

Main Therapeutic Indication : Gastrointestinal Diseases

Currency : USD

2023 Revenue in Millions : 37

2022 Revenue in Millions : 70

Growth (%) : -41

blank

02

Brand Name : Stronger Neo-Minophagen C and Glycyron

Glycyrrhizin preparation

arrow
ELCC
Not Confirmed

Brand Name : Stronger Neo-Minophagen C and Glycyron

arrow
ELCC
Not Confirmed

Glycyrrhizin preparation

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 95

2016 Revenue in Millions : 82

Growth (%) : 16

blank

03

Brand Name : Stronger Neo-Minophagen C And Glycyron

Glycyrrhizin Preparation

arrow
ELCC
Not Confirmed

Brand Name : Stronger Neo-Minophagen C And Glycyron

arrow
ELCC
Not Confirmed

Glycyrrhizin Preparation

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 96

2017 Revenue in Millions : 89

Growth (%) : 8%

blank